Stefan Kasper-Virchow

Stefan Kasper-Virchow

Publications

2026

An explainable transformer model learning from entire treatment timelines for pan-cancer risk profiling across healthcare systems Philipp Keyl, Niklas Kiermeyer, Jonah Bosserhoff, Tim Lenfers, Thibault Niederhauser, Bowen Fan, Thomas Schnake, Simon Schallenberg, Fabio Aubele, Solveig Kuss, Mina Jamshidi Idaji, Philipp Jurmeister, Moon Kim, Sebastian Bauer, Nikolaos Bechrakis, Michael Forsting, Dagmar Führer-Sakel, Martin Glas, Viktor Grünwald, Boris Hadaschik, Ken Herrmann, Stefan Kasper-Virchow, Rainer Kimmig, Stephan Lang, Ina Pretzell, Tienush Rassaf, Alexander Rösch, Jens T. Siveke, Maja Guberina, Ulrich Sure, Marc Wichert, Michael Ingrisch, Kristian Unger, Jürgen Behr, Daniel Teupser, Christian G. Stief, Julia Mayerle, Nadia Harbeck, Amanda Tufman, Jens Ricke, Lars H. Lindner, Siegfried Priglinger, Günter Höglinger, Sven Mahner, Martin Canis, Lucie Heinzerling, Christine Spitzweg, Alpaslan Tasdogan, Matthias Totzeck, Anja Welt, Marcel Wiesweg, C. Benedikt Westphalen, Reinhard Thasler, Fady Albashiti, Grégoire Montavon, Nicola Miglino, Zsolt Balazs, Michael von Bergwelt-Baildon, Volker Heinemann, Claus Belka, Sylvia Hartmann, Andreas Wicki, Felix Nensa, Dirk Schadendorf, Michael Krauthammer, Klaus-Robert Müller, Martin Schuler, Frederick Klauschen, Jens Kleesiek, Julius Keyl medRxiv Large language models enable prognostic stratification of cancer patients using real-world clinical notes Niklas Kiermeyer, Tim Lenfers, Amin Dada, Julian Friedrich, Sameh Khattab, Eric Knop, Jan Egger, Markus Pauly, Andreas Jung, Grégoire Montavon, Jens T. Siveke, Marcel Wiesweg, Stefan Kasper-Virchow, Ulf Peter Neumann, Frederick Klauschen, Sylvia Hartmann, Martin Schuler, Philipp Keyl, Jens Kleesiek, Julius Keyl PLOS Digital Health Explainable AI Predicts Hematoxicity from Cancer Treatment Using Multimodal Real-World Data Julius Keyl, Philipp Keyl, Tim Lenfers, René Hosch, Niklas Kiermeyer, Simon Schallenberg, Moon Kim, Sebastian Bauer, Nikolaos Bechrakis, Michael Forsting, Dagmar Führer-Sakel, Sied Kebir, Viktor Grünwald, Boris Hadaschik, Johannes Haubold, Ken Herrmann, Stefan Kasper-Virchow, Rainer Kimmig, Stephan Lang, Tienush Rassaf, Alexander Rösch, Dirk Schadendorf, Jens T. Siveke, Martin Stuschke, Ulrich Sure, Matthias Totzeck, Anja Welt, Marcel Wiesweg, Jan Egger, Sylvia Hartmann, Grégoire Montavon, Felix Nensa, Klaus-Robert Müller, Martin Schuler, Jens Kleesiek, Frederick Klauschen medRxiv Deep Learning-derived Sarcopenia Marker Predicts Benefit from Anti-EGFR Therapy in Patients with RAS Wild-Type Metastatic Colorectal Cancer Julius Keyl, René Hosch, Fabian Hörst, Philipp Keyl, Amin Dada, Johannes Haubold, Jannis Straus, Jan Egger, Arndt Stahler, Annika Kurreck, Alexej Ballhausen, Sebastian Stintzing, Stefan Frühauf, Lothar Müller, Annabel H. S. Alig, Tanja Trarbach, Sylvia Hartmann, Felix Nensa, Jens Kleesiek, Stefan Kasper-Virchow, Martin Schuler, Dominik P. Modest Clinical Cancer Research

2025

Automated CT-based sarcopenia assessment for risk stratification of patients undergoing colorectal cancer resection Johannes Vogelsang, Gernot Pucher, Fabian Hörst, René Hosch, Johannes Haubold, Philipp Keyl, Christopher Sauer, David Albers, Peter Markus, Jan P. Neuhaus, Andreas D. Rink, Jürgen Treckmann, Ulf Peter Neumann, Kai Nassenstein, Michael Forsting, Hideo A. Baba, Jan Egger, Stefan Kasper-Virchow, Martin Schuler, Felix Nensa, Jens Kleesiek, Julius Keyl Clinical Surgical Oncology Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratification Katarzyna Borys, Johannes Haubold, Julius Keyl, Maria A. Bali, Riccardo De Angelis, Kévin Brou Boni, Nicolas Coquelet, Judith Kohnke, Giulia Baldini, Lennard Kroll, Sara Schramm, Andreas Stang, Eugen Malamutmann, Jens Kleesiek, Moon Kim, Stefan Kasper-Virchow, Jens T. Siveke, Marcel Wiesweg, Anja Merkel-Jens, Benedikt Michael Schaarschmidt, Viktor Grünwald, Sebastian Bauer, Arzu Oezcelik, Servet Bölükbas, Ken Herrmann, Rainer Kimmig, Stephan Lang, Jürgen Treckmann, Martin Stuschke, Boris Hadaschik, Lale Umutlu, Michael Forsting, Dirk Schadendorf, Christoph M. Friedrich, Martin Schuler, René Hosch, Felix Nensa npj Digital Medicine Virtual reality support during systemic cancer therapy to improve anxiety/depressive symptoms and reduce toxicity in patients with gastrointestinal cancers—OncoVR Stefan Kasper-Virchow, S. Liszio, K. Schorrmann, M. Gerigk, S. Jovic, Oliver Basu, K. Kostbade, B. Goraus, Abdelrahman Elsakka, Behrus Puladi, Jens Kleesiek, Martin Schuler, Gijs Luijten, Jan Egger ESMO Gastrointestinal Oncology Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence Julius Keyl, Philipp Keyl, Grégoire Montavon, René Hosch, Alexander Brehmer, Liliana Mochmann, Philipp Jurmeister, Gabriel Dernbach, Moon Kim, Sven Koitka, Sebastian Bauer, Nikolaos Bechrakis, Michael Forsting, Dagmar Führer-Sakel, Martin Glas, Viktor Grünwald, Boris Hadaschik, Johannes Haubold, Ken Herrmann, Stefan Kasper-Virchow, Rainer Kimmig, Stephan Lang, Tienush Rassaf, Alexander Rösch, Dirk Schadendorf, Jens T. Siveke, Martin Stuschke, Ulrich Sure, Matthias Totzeck, Anja Welt, Marcel Wiesweg, Hideo A. Baba, Felix Nensa, Jan Egger, Klaus-Robert Müller, Martin Schuler, Frederick Klauschen, Jens Kleesiek Nature Cancer ABO-Blood Group Associates With Survival Outcomes in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy Franziska Certa, Peter A. Horn, Julius Keyl, Bastian Mende, Smiths Lueong, Thomas Hilser, Sarah Theurer, Isabel Virchow, Yasmin Zaun, Michael Pogorzelski, Martin Metzenmacher, Halime Kalkavan, Stefan Kasper-Virchow, Martin Schuler, Marcel Wiesweg, Gregor Zaun Thoracic Cancer